2020
DOI: 10.3390/pr8080938
|View full text |Cite
|
Sign up to set email alerts
|

Supercritical Antisolvent Process for Pharmaceutical Applications: A Review

Abstract: The supercritical antisolvent (SAS) technique has been widely employed in the biomedical field, including drug delivery, to obtain drug particles or polymer-based systems of nanometric or micrometric size. The primary purpose of producing SAS particles is to improve the treatment of different pathologies and to better the patient’s compliance. In this context, many active compounds have been micronized to enhance their dissolution rate and bioavailability. Aiming for more effective treatments with reduced side… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
49
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 78 publications
(49 citation statements)
references
References 158 publications
(437 reference statements)
0
49
0
Order By: Relevance
“…The solute to be nanonized has to be soluble in the selected liquid solvent but insoluble in the solvent-antisolvent binary mixture formed in the precipitation chamber. Therefore, when the liquid solution (solvent + solute) is injected through the nozzle into the precipitator filled with scCO2, the solute precipitates due to the supersaturation caused by the fast diffusion of scCO2 into the droplets formed after the jet breakup [90]. Nanoparticles are usually produced via the SAS process by working with low temperatures (in the range 35-50 °C ) and pressures equal to or mostly higher than 9 MPa in the precipitation chamber.…”
Section: Production Of Nanoparticles By Using Co 2 As An Antisolventmentioning
confidence: 99%
“…The solute to be nanonized has to be soluble in the selected liquid solvent but insoluble in the solvent-antisolvent binary mixture formed in the precipitation chamber. Therefore, when the liquid solution (solvent + solute) is injected through the nozzle into the precipitator filled with scCO2, the solute precipitates due to the supersaturation caused by the fast diffusion of scCO2 into the droplets formed after the jet breakup [90]. Nanoparticles are usually produced via the SAS process by working with low temperatures (in the range 35-50 °C ) and pressures equal to or mostly higher than 9 MPa in the precipitation chamber.…”
Section: Production Of Nanoparticles By Using Co 2 As An Antisolventmentioning
confidence: 99%
“…Solid dispersions can be produced by various processes, such as co-grinding, spray drying, anti-solvent precipitation, and melt extrusion [ 7 , 8 ]. The SAS process has been widely exploited for several decades to develop solid dispersions for various medical applications, and hundreds of related papers have been published [ 20 , 60 ].…”
Section: Applications Of Sas Process For Solid Multicomponent Systemsmentioning
confidence: 99%
“…The use of scCO 2 eliminates the solvent residues. Finally, after the washing step, there is a depressurization in the precipitator to atmospheric pressure to collect the resulting powder [ 82 , 109 , 110 ].…”
Section: Biopesticide Encapsulation Based On Supercritical Fluid Technologymentioning
confidence: 99%
“…Compared to other techniques such as RESS and spray-drying, the particles formed by SAS present a narrower particle size distribution and higher specific surface area [ 110 ]. Among the limitations of SAS, some stand out, such as the difficulty in working with molecules soluble in CO 2 or the solvent/antisolvent mixture, and with hydrophilic compounds, since there is a notable difference between water and CO 2 solubility in SAS conditions [ 82 ].…”
Section: Biopesticide Encapsulation Based On Supercritical Fluid Technologymentioning
confidence: 99%